Luigi Franchi - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Luigi Franchi

Showing results (81-90 of 86) with videos related to

Pageof 9

Sort By:

You have reached the last page of results.This site can display upto 86 results.

Cancer & Metabolism|April 4, 2026

Tumor cell death by ferroptosis contributes to an immunosuppressive tumor microenvironment in syngeneic murine models of cancerNneka E Mbah, Damien Sutton, Hanna S Hong, et al.

Science Immunology|November 18, 2022

OXPHOS promotes apoptotic resistance and cellular persistence in T<sub>H</sub>17 cells in the periphery and tumor microenvironmentHanna S Hong, Nneka E Mbah, Mengrou Shan, et al.

Nature Immunology|September 14, 2010

Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetesSeth L Masters, Aisling Dunne, Shoba L Subramanian, et al.

Journal of Medicinal Chemistry|March 4, 2025

Discovery of DFV890, a Potent Sulfonimidamide-Containing NLRP3 Inflammasome InhibitorDong-Ming Shen, Kate F Byth, Damien Bertheloot, et al.

Journal of Medicinal Chemistry|April 1, 2025

Correction to "Discovery of DFV890, a Potent Sulfonimidamide-Containing NLRP3 Inflammasome Inhibitor"Dong-Ming Shen, Kate F Byth, Damien Bertheloot, et al.

Nature Communications|October 17, 2024

Therapeutic targeting of differentiation-state dependent metabolic vulnerabilities in diffuse midline gliomaNneka E Mbah, Amy L Myers, Peter Sajjakulnukit, et al.

Pageof 9

Search research articles

Showing results (81-90 of 86) with videos related to

Sort By:

Pageof 9

You have reached the last page of results.This site can display upto 86 results.

Cancer & Metabolism|April 4, 2026

Tumor cell death by ferroptosis contributes to an immunosuppressive tumor microenvironment in syngeneic murine models of cancerNneka E Mbah, Damien Sutton, Hanna S Hong, et al.

Science Immunology|November 18, 2022

OXPHOS promotes apoptotic resistance and cellular persistence in T<sub>H</sub>17 cells in the periphery and tumor microenvironmentHanna S Hong, Nneka E Mbah, Mengrou Shan, et al.

Nature Immunology|September 14, 2010

Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetesSeth L Masters, Aisling Dunne, Shoba L Subramanian, et al.

Journal of Medicinal Chemistry|March 4, 2025

Discovery of DFV890, a Potent Sulfonimidamide-Containing NLRP3 Inflammasome InhibitorDong-Ming Shen, Kate F Byth, Damien Bertheloot, et al.

Journal of Medicinal Chemistry|April 1, 2025

Correction to "Discovery of DFV890, a Potent Sulfonimidamide-Containing NLRP3 Inflammasome Inhibitor"Dong-Ming Shen, Kate F Byth, Damien Bertheloot, et al.

Nature Communications|October 17, 2024

Therapeutic targeting of differentiation-state dependent metabolic vulnerabilities in diffuse midline gliomaNneka E Mbah, Amy L Myers, Peter Sajjakulnukit, et al.

Pageof 9